Cabela’s Inc. to Explore Strategic Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Outlook Therapeutics (OTLK) halted, news pending
Cabela’ (CAB) PT Lifted to $56 at MKM Partner as Company Purses Alternatives
December 2, 2015 4:49 PM ESTMKM Partners reiterated a Buy rating on Cabela's (NYSE: CAB), and raised the price target to $56.00 (from $45.00), as the company announced this morning that it was working with Guggenheim Securities to help it explore ways of driving further shareholder value. CAB has not set a time table for the review, and does not intend... More
Cabela's (CAB) Announces Plans to Explore Alternatives
December 2, 2015 6:30 AM ESTCabela's (NYSE: CAB) announced that its Board of Directors is initiating a process to explore and evaluate a wide range of strategic alternatives to further enhance shareholder value.
We continue to believe that our Vision 2020 strategy will position Cabelas to be the worlds best omni-channel retailer, while driving improved performance in both revenue growth and profitability, said Tommy Millner, Cabelas Chief Executive Officer. That said, the Board is committed to taking actions to enhance value for shareholders and believes it is an appropriate time to explore... More
